Inovio Pharmaceuticals, Inc.
Cancer vaccines and methods of treatment using the same

Last updated:

Abstract:

The invention provides a vaccine comprising a nucleic acid molecule that encodes a dog telomerase reverse transcriptase (dTERT) antigen, as well as methods of using the vaccine to induce an immune response against a TERT and to treat cancer in a mammal.

Status:
Grant
Type:

Utility

Filling date:

3 Feb 2017

Issue date:

18 May 2021